Having demonstrated the relationship between early NSCLC and nuclear P-s207 LysRS (especially in the EGFR mutated group), we proceeded to examine the latter’s correlation with improved disease-free survival (DFS) using Kaplan-Meier plots for NSCLC patients with wild type or mutated EGFR (Figure 4A-4D). This evidence concerns the gene EGFR and non-small cell lung carcinoma.